Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000950168-00-000018
Filing Date
2000-01-06
Accepted
2000-01-06 00:00:00
Documents
11
Period of Report
1999-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K405 10-K405 206417
2 AMENDMENT TO BYLAWS EX-3.3 328
3 FORM OF STOCK CERTIFICATE EX-4.1 2041
4 AMEND #2 TO RESEARCH AGR. DATED 6/22/99 EX-10.45 3668
5 AMEND #2 TO RESEARCH AGR. DATED 7/1/97 EX-10.46 3959
6 SEVERANCE AGREEMENT EX-10.47 14674
7 ASSET PURCHASE AGREEMENT EX-10.48 81844
8 STATEMENT RE COMPUTATION OF NET LOSS EX-11.1 1432
9 LIST OF SUBSIDIARIES EX-21.1 302
10 ACCOUNTANTS CONSENT EX-23.1 784
11 FINANCIAL DATA SCHEDULE EX-27.1 3103
  Complete submission text file 0000950168-00-000018.txt   321192
Mailing Address PO BOX 14287 PO BOX 14287 RESEARCH TRIANGLE PK NC 27709
Business Address 3200 E HIGHWY STE 300 PO BOX 14287 CAPE FEAR BLDG STE 101 RESEARCH TRIANGLE PA NC 27709 9195588688
INCARA PHARMACEUTICALS CORP (Filer) CIK: 0000936538 (see all company filings)

EIN.: 561924222 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K405 | Act: 34 | File No.: 000-27410 | Film No.: 502587
SIC: 2834 Pharmaceutical Preparations